Alice Matthews

London UK

Alice assists clients with a wide range of matters relating to the commercialisation of intellectual property rights and a broad range of regulatory and compliance issues concerning healthcare, industrial and consumer products prior to and after launch. She also assists with product safety issues, including supporting in risk management/compliance assessments.

CV

Since 2023 Associate, Taylor Wessing

2021 - 2023 Trainee Solicitor, Taylor Wessing

Karriere

Since 2023 Associate, Taylor Wessing

2021 - 2023 Trainee Solicitor, Taylor Wessing

Ausbildung

2024 Postgraduate Diploma in Intellectual Property Law and Practice, University of Oxford

2023 Admitted as a lawyer, England & Wales

2021 LLM in Commercial Legal Practice, BPP University

Publikationen

An overview of cybersecurity requirements for medical devices – the EU and UK regulatory landscape, Journal of Medical Device Regulation, Volume 19 Issue 3, Edward Spencer & Alice Matthews, August 2022, pages 1-10.

Experience

Advising an Australia-based investment firm

Advising an Australia-based investment firm on its investment in a global telehealth company providing weight loss prescription services in the UK and Germany.

Alice Matthews

Advising a clinical-stage biopharmaceutical company

Advising a clinical-stage biopharmaceutical company in administration on the transfer to a purchaser of the rights to a medical device product.

Alice Matthews

Advising a MedTech university spin-out

Advising a MedTech university spin-out company on the drafting and negotiation of a strategic partnership with a global top-10 medical device company.

Alice Matthews

Rockpool Investments

Advising Rockpool Investments on its acquisition on orthoses and clinical services provider Talar-Made Ltd.

Press release

Alice Matthews

Nicholas Vollers

Essential Pharma

Advising Essential Pharma on its acquisition of European rights to Colobreathe® from Teva Laboratories UK Limited.

Press release

Alice Matthews

News & Insights: Alice Matthews

Zu den Insights

Klicken Sie hier für Details

Arzneimittel

Biopharma partnering update: Q4 2025

25. Februar 2026

von mehreren Autoren

Life Sciences & Healthcare

Advertising skinny jabs – regulators react

15. Oktober 2025

Quick read

von Alison Dennis und Alice Matthews

Klicken Sie hier für Details

Synapse - Europe's approach to supply chain issues for medicines and medical devices

EU and medicines supply issues (part two): Proposals for future measures

In part two of our article on EU and medicine supply issues we explore the key proposals outlined in pharmaceutical reform and their impact on marketing authorisation holders across the region.

1. Oktober 2025

Quick read

von Alison Dennis und Alice Matthews

3 von 5 Insights

Klicken Sie hier für Details

Expertise

Rechtsgebiete und Gruppen

Branchen